Pharmaceuticals

Kidney Fibrosis Treatment Market to Grow at a CAGR of 7.9% from 2025 to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Kidney Fibrosis Treatment Market?

The market size for kidney fibrosis treatment has shown substantial growth recently. It is projected to expand from $5.62 billion in 2024 to $6.06 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. This historical expansion is largely due to several factors, including escalating investments in research and development for therapies targeting fibrosis, a rise in government funding aimed at kidney disease management initiatives, enhanced patient understanding of kidney transplantation and available fibrosis treatment choices, improvements in healthcare infrastructure, and the growing incidence of aging populations.

The kidney fibrosis treatment market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $8.21 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.9%. This anticipated growth during the forecast period is primarily driven by the escalating occurrence of chronic kidney diseases, a heightened need for sophisticated treatments in managing renal fibrosis, increased recognition of the importance of detecting kidney fibrosis early, wider acceptance of personalized medicine approaches for kidney conditions, and the growing rates of diabetes and hypertension. Key trends expected over this period encompass technological progress in diagnostic and early detection methods, innovations in gene therapy, the incorporation of technology into telemedicine and remote monitoring, developments in stem cell therapies, and improvements in drug delivery systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24271&type=smp

Which Drivers Are Supporting Growth Of The Kidney Fibrosis Treatment Market?

The market for kidney fibrosis treatment is anticipated to expand due to the growing occurrence of chronic kidney diseases. Chronic Kidney Disease (CKD) signifies a progressive decline in kidney function over time, frequently caused by ailments like diabetes or hypertension, leading to the buildup of toxins within the body. A significant contributor to the increasing incidence of CKD is the escalating prevalence of diabetes, which harms renal blood vessels and compromises their filtration capabilities. Kidney fibrosis treatment aids patients with Chronic Kidney Disease (CKD) by addressing the scarring of renal tissue, mitigating inflammation, and decelerating the advance of kidney damage, thereby preserving kidney function. For example, data from May 2024, provided by the Centers for Disease Control and Prevention (CDC), a US-based public health agency, indicated that an estimated 14% of U.S. adults, equating to about 35.5 million people, are thought to have chronic kidney diseases. Consequently, the expanding occurrence of chronic kidney diseases is fueling the expansion of the kidney fibrosis treatment market.

How Is The Kidney Fibrosis Treatment Market Classified Into Different Segments?

The kidney fibrosis treatment market covered in this report is segmented –

1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types

2) By Diagnosis: Blood Tests, Urine Tests, Imaging Tests, Kidney Biopsy

3) By Application: Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications

4) By End-User: Clinics, Research Center, Hospitals

Subsegments:

1) By Angiotensin-Converting Enzyme (Ace) Inhibitors: Enalapril, Captopri, Lisinopril, Ramipril

2) By Angiotensin Ii Receptor Blockers (Arbs): Losartan, Telmisartan, Valsartan, Irbesartan

3) By Pirfenidone: Branded Pirfenidone, Generic Pirfenidone

4) By Renin Inhibitors: Aliskiren, Experimental Renin Inhibitors

5) By Vasopeptidase Inhibitors: Omapatrilat, Sampatrilat

6) By Other Treatment Types: Anti-Inflammatory Agents, Stem Cell Therapy, Antifibrotic Agents Under Clinical Trials, Gene Therapy

Which Industry Leaders Are Driving Innovation Across The Kidney Fibrosis Treatment Market?

Major companies operating in the kidney fibrosis treatment market are F. Hoffman-La Roche Ltd., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Cara Therapeutics Inc., Gilead Sciences Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Vertex Pharmaceuticals Incorporated, Chinook Therapeutics Inc., Reata Pharmaceuticals Inc., Akebia Therapeutics Inc., Travere Therapeutics Inc., Insilico Medicine Inc., Tvardi Therapeutics Inc., ProKidney LLC, Alentis Therapeutics AG, La Jolla Pharmaceutical Company, Galecto Biotech AB, Purespring Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/kidney-fibrosis-treatment-global-market-report

Which Regional Markets Are Contributing Most To The Kidney Fibrosis Treatment Industry Expansion?

North America was the largest region in the kidney fibrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney fibrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Kidney Fibrosis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24271&type=smp

Browse Through More Reports Similar to the Global Kidney Fibrosis Treatment Market 2025, By The Business Research Company

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Artificial Kidney Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

Rare Kidney Diseases Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795